Skip to content

    Inve Blog

    The Growth Funding Engine: Who Pays for Growth?

    Raising money to grow isn't the sin — raising it for growth that doesn't pay is. We read every FY24 funded bet, and what management is telling investors now.

    Inve Content Team · 22 June 2026

    For years I flinched whenever a company I owned announced it was raising money to grow — fresh debt, a share sale, a big acquisition. It felt like management reaching into my pocket. That instinct cost me. It kept me out of some of the best businesses I ever looked at — the ones that borrowed a rupee and turned it into three.

    Raising money to grow isn't the sin. Raising it to buy growth that doesn't pay — that is the sin. And on the day of the announcement, the two look exactly alike.

    There are only two endings

    Every rupee of growth comes from somewhere: the company's own cash, a lender, or new shareholders. Where it comes from is worth knowing. But it settles nothing, because the story ends one of only two ways. Either the growth that money buys earns more than the money costs — borrow all you sensibly can — or it doesn't, and it becomes a slow leak with a press release attached.

    Picture a shopkeeper who borrows ₹10 lakh. Open a second store that throws off ₹3 lakh a year, and the loan was the smartest thing he ever did. Spend it on a grander signboard for the same shop, and he now owes ₹10 lakh and sells exactly as many samosas as before. Same loan. Opposite life.

    We read every one of them — and it's a coin flip

    We went through every listed company that funded a real step-change in growth in one specific year, FY24 — fixed assets up by half or more, paid for with fresh debt or fresh equity — and read the profit after the same two-year gap, at FY26. Same starting line, same finish line for all of them, so the only thing that differs is whether the money worked. Sixty-one companies cleared that bar.

    Of those 61 funded bets, only 33 had more profit to show for it. Twenty-eight did not — and 16 were bigger and poorer: more revenue, less profit than before they spent (Inve data, 2026). Close to a coin flip on the one thing you actually own — the profit. The capital almost always buys revenue. Less than half the time, so far, has it bought earnings.

    It isn't the industry — it splits inside the same sector

    You can't dodge this by picking the "right" sector. The same year, the same funding move, the same kind of customer — and one company's bet earned while its neighbour's didn't:

    SectorRaised in FY24 — and it paid (PAT, FY23→FY26)Raised in FY24 — and it hasn't (yet)
    Real estateGodrej Properties — ₹620 → ₹1,840 crPuravankara — ₹67 cr → a ₹54 cr loss
    QSR / restaurantsJubilant (Domino's) — ₹354 → ₹362 crDevyani (KFC, Pizza Hut) — ₹263 cr → a ₹33 cr loss
    Specialty chemicalsAtul — ₹506 → ₹689 crPCBL — ₹441 → ₹198 cr

    Same sector each row. The sector didn't decide it; the return on what the money bought did.

    What management is telling investors right now

    The numbers are the scoreboard. The concalls are the players explaining the game — and read together, they're far more honest than the headline. (Most of these companies raised or committed the money back in FY24, before our transcript record begins; the calls below are the recent ones, where management grades its own bet.)

    PCBL — "the impact is yet to come." PCBL borrowed heavily to buy Aquapharm, carrying net debt near ₹5,000 crore. Two years on, it has missed every profitability target it set for the deal — Aquapharm did ₹29 crore of quarterly EBITDA against an ₹80–90 crore goal. On the April 2026 call, management's own words: "The real impact of all the initiatives… is yet to come. It is still not reflected in the performance." Translation, in owner's terms: the interest bill is here; the profit isn't, and the payoff has been pushed to FY27. (To their credit, the company is paying the debt down from its own cash — ₹454 crore last year.)

    Devyani — bigger, and eating itself. Devyani took its KFC and Pizza Hut count to roughly three-to-four times its old base. The stores arrived; the profit turned into a loss. In February 2026 the CFO said the quiet part plainly: open stores at that pace and "there will be some amount of cannibalization which will seep in." Pizza Hut now runs at break-even, new-store building there is frozen, and the company is leaning on a merger to find the scale that justifies what it built.

    Jubilant — the same store blitz, carrying its weight. Same business, same fuel — Domino's expanded hard too. The difference is in the result: profit roughly doubled year-on-year by late FY26 and margins are climbing back, with management targeting "above FY24 margins… improve by about 200 bps." The new stores, so far, are paying for themselves. Same sector as Devyani; opposite ending.

    Godrej Properties — converting, cash deferred. It raised equity and poured money into land — ₹2,000 crore of land in a single quarter. The bet is showing up: record bookings of ₹34,171 crore and FY26 profit up 32% to ₹1,850 crore. But the chairman is honest about the lag — "I expect certainly FY28 to be strongly free cash flow positive." The growth is real; the cash is a year or two out.

    Puravankara — the live reminder that two years isn't the last word. On the full-year FY26 numbers it's the loss-maker in the table. But its latest quarter turned profitable, and the chairman's framing of the debt-funded landbank is the whole thesis in one line: "₹2,000 crores of debt increase has resulted in more than ₹30,000 crores of capability to develop — that's a 15x return on the capital deployed." If he's right, this is a "not yet" becoming a "yes." If he's wrong, it's the signboard. The next few prints will settle it.

    See it on a live earnings call

    Browse AI-analysed concall summaries — guidance tables, graded Q&A, and the quotes behind them — for 1,500+ listed Indian companies.

    Browse concall summaries

    Be fair — and watch for the confounders

    Two years is not the last word, and the raw profit line can lie about the bet. Puravankara may already be turning. And the number can move for reasons that have nothing to do with the funding: a company can grow handsomely without raising a rupee (a net-cash compounder funding capacity from its own cash flow), and a single bad event — a fire, a plant accident, a one-off — can sink a year's profit no matter how good the expansion was. So don't read one weak print as a failed bet. Read the operating return on the new capacity, over time, and listen to whether management is explaining a delay or explaining away a mistake.

    How to read it in one pass

    When a company excites you about how much it will grow:

    • Where's the fuel? Own cash flow, debt, or new shares — the balance sheet shows it: rising fixed assets is the spend; a jump in borrowings or share count is outside fuel; falling debt or a buyback is the engine handing fuel back.
    • Did the growth out-earn the fuel — and what does management now say? Read the profit and return on capital a year or two after the spend, then read the recent concall. Is management showing the payoff (Jubilant, Godrej), or explaining why it's "yet to come" (PCBL)? Judge the bet by the earnings it threw off, not the cheque that started it.

    Cheer the second store. Be wary of the signboard. And give every funded bet two years before you call it.

    Watch it resolve — don't take the press release on faith

    When money is raised, management always says it will pay — "accretive," "internal accruals," "deleveraging from cash flow." Across the commitments tracked on Inve, barely half are delivered as stated, and capital-and-funding lines are among the first to go quiet when the plan disappoints — PCBL's own "Debt/EBITDA below 3 by FY26" is logged as missed. So follow the bet, quarter by quarter: is the new capacity adding to profit, or only to revenue and interest? Inve's Promise Tracker keeps that record across quarters, and the funding plans and these quotes sit in the concall summaries.

    The slide shows you the speed. The quieter question makes you money: this company spent to grow — two years on, is what it bought worth more than what it paid?

    Frequently asked questions

    Inve is a research and analysis platform, not an investment adviser. Nothing here is a recommendation to buy or sell any security. Do your own research or consult a SEBI-registered adviser before investing.

    Inve is a research and analysis platform, not an investment adviser. Nothing here is a recommendation to buy or sell any security. Do your own research or consult a SEBI-registered adviser before investing.